Receptor-mediated radiotherapy with 90Y-DOTA-D-Phe1-Tyr3-octreotide.
Paganelli G, Zoboli S, Cremonesi M, Bodei L, Ferrari M, Grana C, Bartolomei M, Orsi F, De Cicco C, Mäcke HR, Chinol M, de Braud F.
Paganelli G, et al. Among authors: macke hr.
Eur J Nucl Med. 2001 Apr;28(4):426-34. doi: 10.1007/s002590100490.
Eur J Nucl Med. 2001.
PMID: 11357492
Clinical Trial.